| Original language | English |
|---|---|
| Pages (from-to) | 2183-2186 |
| Number of pages | 4 |
| Journal | Pediatric Pulmonology |
| Volume | 58 |
| Issue number | 8 |
| Early online date | 2023 |
| DOIs | |
| Publication status | Published - Aug 2023 |
Bibliographical note
Funding Information:Drs Alexopoulou, Bush, Constant, Douros, Fortescue, Griese, Hector, Karadag, Hill, Kantar, Mazulov Midulla, Moeller, Proesmans, Yerkovich, Zacharasiewicz have nothing to disclose. Ms Boyd, Powell and Wilson, and Mr Collaro also have nothing to disclose. Drs Chang and Grimwood report grants from the National Health and Medical Research Council, and the Medical Research Futures Fund, Australia, during the conduct of the study. Dr Chang is also an independent data management committee member for clinical trials of an unlicensed vaccine (GlaxoSmithKline), and monoclonal antibody (AstraZeneca); an advisory member of study design for an unlicensed product for chronic cough (Merck), and personal fees from being an author of two UpToDate chapters that are outside the submitted work. Dr Chalmers reports grants, and personal fees from AstraZeneca, grants, and personal fees from Boehringer Ingelheim, personal fees from Chiesi, grants and personal fees from GlaxoSmithKline, grants from Gilead Sciences, grants and personal fees from Insmed, personal fees from Novartis, and personal fees from Zambon that are outside the submitted work. Dr Grigg reports grants and personal fees from OM Pharma, personal fees from GlaxoSmithKline, personal fees from Novartis, personal fees from Omron, and personal fees from AstraZeneca that are outside the submitted work. Dr Zacharasiewicz reports personal fees for lectures from AstraZeneca, personal fees for lectures from Chiesi, and personal fees from Vertex Pharmaceuticals, personal fees from Novartis, and personal fees from Sanofi that are outside the submitted work.
